Growth Equity Opportunities V, LLC
Related Filers (7)
- Regulus Therapeutics Inc. (9)
- Trillium Therapeutics Inc. (6)
- NEA 16 GP, LLC (5)
- New Enterprise Associates 16, L.P. (5)
- NEA Partners 16, L.P. (5)
- CTI BIOPHARMA CORP (5)
- MEI Pharma, Inc. (3)
- Show More ...
Ownership (23)
SC 13D/A
Friday, 5/12/2023
Regulus Therapeutics Inc.: Major Shareholders
SC 13D/A
Thursday, 3/9/2023
MEI Pharma, Inc.: Major Shareholders
SC 13D/A
Friday, 7/22/2022
CTI BIOPHARMA CORP: Major Shareholders
SC 13D/A
Friday, 6/17/2022
CTI BIOPHARMA CORP: Major Shareholders
SC 13D/A
Thursday, 12/9/2021
Regulus Therapeutics Inc.: Major Shareholders
SC 13D/A
Friday, 11/19/2021
Trillium Therapeutics Inc.: Major Shareholders
SC 13D/A
Wednesday, 9/1/2021
Trillium Therapeutics Inc.: Major Shareholders
4
Tuesday, 3/16/2021
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/7/2020
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 3/12/2020
CTI BIOPHARMA CORP: Major Shareholders
SC 13D/A
Thursday, 2/13/2020
CTI BIOPHARMA CORP: Major Shareholders
SC 13D/A
Tuesday, 2/4/2020
Trillium Therapeutics Inc.: Major Shareholders
SC 13D/A
Monday, 12/30/2019
MEI Pharma, Inc.: Major Shareholders
4
Thursday, 12/26/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/15/2019
Regulus Therapeutics Inc.: Major Shareholders
4
Thursday, 5/9/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 3/4/2019
Trillium Therapeutics Inc.: Major Shareholders
SC 13D
Wednesday, 5/23/2018
MEI Pharma, Inc.: Major Shareholders
SC 13D
Tuesday, 2/20/2018
CTI BIOPHARMA CORP: Major Shareholders
SC 13D/A
Tuesday, 12/5/2017
Trillium Therapeutics Inc.: Major Shareholders
SC 13D
Wednesday, 8/2/2017
Regulus Therapeutics Inc.: Major Shareholders
3
Monday, 7/31/2017
Regulus Therapeutics Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 6/9/2017
Trillium Therapeutics Inc.: Major Shareholders